'Can Activate Malware, Bugs': Govt To Probe Security Risks From Chinese Medical Devices
Amid rising national security concerns, the government is investigating Chinese IoT-enabled medical devices in remote areas, fearing they could leak sensitive health data and compromise defence interests, News18 has learnt.
A concern was raised during a meeting chaired by Union commerce and industry minister Piyush Goyal, flagging potential national security and data privacy risks. The ministry has ordered an examination into the growing use of Chinese IoT-enabled medical devices in remote Indian health facilities.
An official document reviewed by News18 outlines concerns over the potential misuse of data by Chinese firms, particularly through medical imaging and monitoring devices. These devices, which are now being widely used in rural healthcare settings, have been identified as potential conduits for surveillance and unauthorised data access.
'Deployment of Chinese medical devices in remote areas raises patient data security concerns… Concern expressed was that the population health data can be misused by Chinese firms (using Chinese-owned medical devices, especially IoT-enabled imaging and monitoring equipment, which are increasingly being installed in remote Indian health facilities)," according to the minutes of the meeting held on July 2.
According to an official who was part of the meeting, 'the concern was discussed with the minister, as it is very easy to insert malware or bugs into the medical devices while exporting. Any hostile nation can play this trick and activate malware or bugs in those devices whenever they want".
'We must understand that such incidents can put thousands of patients using those devices under severe distress. Hence, we need to scrutinise the devices which are coming from hostile nations. The ministry has decided to take this matter seriously and will go deep into it," he said, requesting anonymity.
The commerce ministry has proposed that relevant data be shared with ministries, including the Department of Pharmaceuticals (DoP), Department for Promotion of Industry and Internal Trade (DPIIT) and the Ministry of Health and Family Welfare (MoHFW) for further scrutiny.
Presence of Chinese Medical Devices in India
According to industry data, India continues to rely heavily on Chinese imports for a wide range of medical devices, particularly in critical and high-volume categories. China is the second-largest exporter of medical devices to India, which stood around Rs 11,506 crore in 2023-24, slightly less than the US, which exported devices worth Rs 12,552 crore in the same year.
Some of the top medical equipment imported from China includes patient monitoring systems, diagnostic imaging machines (like ultrasound and CT scanners), in-vitro diagnostic (IVD) kits, oxygen concentrators, surgical instruments, thermometers, orthopaedic implants, and disposable items like syringes and needles. Leading Chinese companies dominating this space include Mindray, United Imaging, Yuwell and Sinocare. These firms, often offering competitively priced technology, have gained strong market presence in India, especially in Tier-II and rural health settings.
The document also highlights transfer pricing violations by Chinese firms, pushing for stronger enforcement through anti-dumping measures and quality control orders (QCOs). The National Pharmaceutical Pricing Authority (NPPA) has been tasked with examining this issue, in consultation with agencies like BIS and CBIC.
First Published:
July 17, 2025, 10:49 IST
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
31 minutes ago
- Time of India
Sribhumi set for 24x7 clean tap water with Rs 81.18cr project boost
Silchar: In a major boost to Barak Valley's infrastructure, Assam's public health engineering minister Jayanta Mallabaruah on Sunday laid the foundation stone for a Rs 81.18 crore drinking water supply project in Sribhumi town under the Jal Jeevan Mission (Urban). Tired of too many ads? go ad free now The initiative aims to deliver 24/7 tap water to over 15,000 households across 27 municipal wards, reaching nearly 75,000 residents. The ceremony at the Langai water plant was marked by traditional bhoomi pujan rituals and attended by ministers Kaushik Rai and Krishnendu Paul, BJP district president Sanjeev Banik, and senior PHE officials. Addressing a gathering at the Sribhumi District Library auditorium, Mallabaruah reiterated the state govt's commitment to Barak Valley's development. He said CM Himanta Biswa Sarma has earmarked Rs 350-400 crore for drinking water projects across the region. "Hailakandi alone has received over Rs 100 crore. Projects for Lala and Badarpur are in the pipeline, and construction will begin soon," the minister said, adding that the AMRUT scheme in Silchar is also progressing. He emphasised that Sribhumi's current water treatment infrastructure — commissioned in 1967 for a population of merely 12,000 — is grossly outdated. "This project is designed to meet the needs of today's Sribhumi," he said. The system will include a 129-km distribution network and five elevated service reservoirs (ESRs), strategically placed to ensure efficient water flow across town. While the project's completion target is December 2028, Mallabaruah urged officials to expedite delivery. "Clean water means fewer hospital visits and a healthier, stronger community," he said.
New Indian Express
an hour ago
- New Indian Express
'We need a healthcare regulator to oversee pricing and practices'
After having spent over four decades in insurance, G Srinivasan has taken on a new challenge as MD and CEO of Galaxy Health Insurance, a Chennai-based standalone health insurer backed by the TVS Group and Star Health founder V Jagannathan. Srinivasan, former CMD of United India and New India Assurance, spoke to The New Indian Express about Galaxy's strategies, targets, market dynamics, and challenges. What led to the launch of Galaxy Health Insurance? The idea was spearheaded by the TVS family and V Jagannathan, who built Star Health into a market leader. Both bring immense credibility. They believed there is still a huge gap in health insurance. Around 40% of India's population remains uninsured, and among those inured, many are underinsured. For instance, a ₹5 lakh cover isn't enough anymore when health care costs are skyrocketing. A short hospital stay can wipe it out. We want to address this in four ways -- by improving penetration in underinsured regions; by designing practical, need-based products; by focusing on wellness; and by ensuring fair and full claim settlement. How quickly have you scaled up since launch? The company was set up in March, 2024. We got our license in under 50 days. By October, we issued our first policy. In just 8–9 months, we have expanded to 65 offices across eight states of Tamil Nadu, Karnataka, Andhra Pradesh, Telangana, Odisha, West Bengal, Assam, and Uttar Pradesh. At present, we have 350 employees, 9,000 agents, and have already covered around one lakh lives. Our goal this year is Rs 200 crore in premium. What is your product strategy? So far, we have launched eight products. Galaxy Promise, our flagship, comes in three variants. Galaxy Marvel is a base plan with add-ons, while our Top-Up product allows customers to enhance coverage at low cost. We have tailored plans for senior citizens, NBFC customers, and group clients. Disease-specific plans for cancer, cardiac care, and diabetes are on the drawing board. We are targeting 90% of our business from retail. For young buyers, we offer a standout feature — if there are no claims, the premium remains constant till age 55. That is rare in this market and encourages early adoption. Are micro-insurance products part of your roadmap? Absolutely. We are rolling out a rural-focused plan in the next 2–3 months. It will be affordable and cater to people using small nursing homes. We are also exploring bite-sized covers like personal accident and critical illness, especially through our corporate agency partners. It is essential to make insurance accessible for underserved populations. Why are premiums rising and what is the way forward? Healthcare costs are rising because there is no regulation. Unlike other sectors, there is no central authority controlling hospital rates or standardising treatment protocols. Health is split between the Centre and states, creating gaps. The Central government has developed a National Claims Exchange for transparent claims processing. All insurers are on board, but only a few hospitals have joined. Beyond tech, we need a healthcare regulator, someone to oversee pricing and practices. Without that, health care costs will rise and consequently premiums will continue to rise, and customers will suffer. How is Galaxy Health handling claims? Claims are a pain point for many, but we have made it our strength. Our products cover even consumables—often excluded elsewhere—so customers get nearly 100% of their expenses reimbursed. In the last 7–8 months, we have settled 200–250 claims with full transparency. We support the regulator's move to allow cashless claims even at non-network hospitals. How do you deal with outpatient care? Most policies only cover inpatient treatment. But a huge chunk of health spending goes to OPD —doctor visits, diagnostics, medicines. We have launched an OPD product that covers consultations, telemedicine, labs, and pharmacies. It has been well received. True health insurance must include both in-patient and outpatient care, plus daycare procedures, which we also cover extensively.
Time of India
an hour ago
- Time of India
Consumer forum orders LIC to pay Rs 21 lakh to complainant
Udupi: The Udupi district consumer disputes redressal commission ordered the LIC of India to pay Rs 21,03,089 with 9% interest to an applicant. The applicant, Srinivasa Nayak from Bannanje, took an LIC policy of Rs 25 lakh on June 28, 2020, for his minor daughter Siri Nayak, with an annual premium of Rs 1,32,304. The policy had a term of 20 years, with a plan to return the full amount on the 21st year, according to the complainant. In June 2022, the applicant's daughter suffered from a severe fever and was treated at a hospital in Udupi. She recovered but suffered from fever again, and despite treatment, she passed away on Feb 18, 2023, at a hospital in Manipal. Born in 2015, in Udupi, the child was healthy at birth with no health issues, and the applicant had paid three annual premiums by the time of her death. After her passing, the applicant submitted all necessary documents to the Udupi LIC office, seeking an insurance claim of Rs 25 lakh. However, the insurance company rejected the claim on April 4, 2024, alleging undisclosed pre-existing health issues at birth, and refunded only Rs 3,96,911, the amount paid in premiums. The applicant then appealed to the Insurance Ombudsman in Bengaluru but the outcome there was also not favourable. Subsequently, a complaint was filed against LIC with Udupi district consumer disputes redressal commission. The commission president Sunil T Masaraddi and member Sujata B Koralli ruled in favour of the applicant, ordering LIC to pay Rs 21,03,089 with 9% interest, along with Rs 25,000 for mental agony and harassment, and Rs 10,000 for litigation costs, stated advocates H Anand Madivala and Deepak Kumar Poojari, who represented the applicant.
